Is this your profile?

About

Sandra de Haan was Chief Business Officer for Sensile Medical (now part of Gerresheimer) until 2017.

Contributions

COMPANY SHOWCASE: Sensile Medical

Sensile Medical has achieved a lot since its acquisition by Gerresheimer last year. Here they provide an update on two recent projects: the recent market launch of our first micropump, an infusion pump for Parkinson’s disease patients; and our latest project with SQ Innovation for a 3 mL furosemide patch pump.

More contributions

PREFERRED BY PATIENTS… WITH IMPROVED THERAPIES

Sandra de Haan describes how the Sensile Medical’s micro pump technology advances have enabled it to develop wearable injector patch pumps to deliver better care for patients.

THE DRIVE UNIT OF THE PATCH PUMP

Gerhard Mayer and Sandra de Haan describe how, together with their pharmaceutical partner scPharmaceuticals (Lexington, MA, US) and Buehler Motor, developed the drive mechanism for a new, soon-to-be launched patch pump.

A LARGE VOLUME SC DELIVERY SYSTEM MUST ADJUST TO DRUG & PATIENT NEEDS

Here, Gerhard Mayer, Sandra de Haan, and Helmut Thiemer describe the SenseCore micro pump and its advantages when applied in the area of large volume injection devices.

Top